1. Home
  2. VALN vs GRPN Comparison

VALN vs GRPN Comparison

Compare VALN & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • GRPN
  • Stock Information
  • Founded
  • VALN 2012
  • GRPN 2008
  • Country
  • VALN France
  • GRPN United States
  • Employees
  • VALN N/A
  • GRPN N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • GRPN Advertising
  • Sector
  • VALN Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • VALN 510.7M
  • GRPN 534.1M
  • IPO Year
  • VALN 2021
  • GRPN 2011
  • Fundamental
  • Price
  • VALN $6.79
  • GRPN $18.99
  • Analyst Decision
  • VALN Strong Buy
  • GRPN Buy
  • Analyst Count
  • VALN 2
  • GRPN 4
  • Target Price
  • VALN $16.00
  • GRPN $17.75
  • AVG Volume (30 Days)
  • VALN 142.9K
  • GRPN 1.6M
  • Earning Date
  • VALN 05-06-2025
  • GRPN 05-08-2025
  • Dividend Yield
  • VALN N/A
  • GRPN N/A
  • EPS Growth
  • VALN N/A
  • GRPN N/A
  • EPS
  • VALN N/A
  • GRPN N/A
  • Revenue
  • VALN $175,564,758.00
  • GRPN $492,557,000.00
  • Revenue This Year
  • VALN $19.17
  • GRPN $2.91
  • Revenue Next Year
  • VALN $26.31
  • GRPN $6.73
  • P/E Ratio
  • VALN N/A
  • GRPN N/A
  • Revenue Growth
  • VALN 10.32
  • GRPN N/A
  • 52 Week Low
  • VALN $3.62
  • GRPN $7.75
  • 52 Week High
  • VALN $9.50
  • GRPN $19.85
  • Technical
  • Relative Strength Index (RSI)
  • VALN 50.63
  • GRPN 69.03
  • Support Level
  • VALN $6.54
  • GRPN $16.04
  • Resistance Level
  • VALN $7.30
  • GRPN $19.85
  • Average True Range (ATR)
  • VALN 0.48
  • GRPN 1.24
  • MACD
  • VALN 0.01
  • GRPN -0.09
  • Stochastic Oscillator
  • VALN 56.79
  • GRPN 78.55

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: